Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 386-390

  Landry, France ^b   Chapdelaine, Alcide ^b   Bégin, Louis R ^b   Chevalier, Simone ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Protein tyrosine kinase; Protein tyrosine phosphatase; Steroids

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ARGININE ESTERASE; CYTOKERATIN; PHOSPHOTYROSINE; POLYCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

ANDROGEN THERAPY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; CASTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOG; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SECRETORY CELL; SIGNAL TRANSDUCTION;

ANDROGENS; ANIMAL; DOGS; EPITHELIAL CELLS; ESTROGENS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PHOSPHOTYROSINE; PROSTATE; PROSTATIC HYPERPLASIA; PROTEIN-TYROSINE KINASE; PROTEIN-TYROSINE-PHOSPHATASE; RABBITS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; UP-REGULATION;

EID: 0029655815     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66665-5     Document Type: Article

References (31)

1. Krebs, E. D.: Protein phosphorylation and cellular regulation I (Nobel Lecture). Angew. Chem. Int. Ed. Engl., 32: 1122, 1993.
2. Fisher, E. H.: Protein phosphorylation and cellular regulation II (Nobel Lecture). Angew. Chem. Int. Ed. Engl., 32: 1130, 1993.
3. Shenolikar, S.: Control of cell function by reversible protein phosphorylation. J. Cyclic Nucleot. Protein Phosphoryl., 11: 531, 1987.
4. Shalloway, D. and Shenoy, S.: Oncoprotein kinases in mitosis. Adv. Cancer Res., 51: 185, 1991.
5. Pawson, T. and Gish, G. D.: SH2 and SH3 domains: from structure to function. Cell, 71: 359, 1992.
6. Li, H. C., Chernoff, J., Chen, L. B. and Kirschowbaum, A.: A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland. Eur. J. Biochem., 138: 45, 1984.
7. Durocher, Y., Chapdelaine, A. and Chevalier, S.: Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145. Cancer Res., 49: 4818, 1989.
8. Bourassa, C., Nguyen, Y., Roberts, K. D. and Chevalier, S.: Prostatic epithelial cells in culture: phosphorylation of protein tyrosyl residues and tyrosine protein kinase activity. J. Cell Biochem., 46: 291, 1991.
9. Bourassa, C., Nguyen, L. T., Roberts, K. D. and Chevalier, S.: Characterization of protein-tyrosine kinase activity in the canine prostate. Biochem. Cell Biol., 69: 146, 1991.
10. McKeehan, W. L.: Growth factor receptors and prostate cell growth. Cancer Surveys, 11: 165, 1991.
11. Graham, C. W., Lynch, J. H. and Djakiew, D.: Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J. Urol., 147: 1444, 1992.
12. Coffey, D. S. and Isaacs, J. T.: Requirements for an idealized animal model of prostatic cancer. Progress Clin. Biol. Res., 37: 379, 1980.
13. Merk, F. B., Warhol, M. J., Kwan, P. W. L., Leav, I., Alroy, J., Ofner, P. and Pinkus, G. S.: Multiple phenotypes of prostatic glandular cells in castrated dogs after individual or combined treatment with androgen and estrogen. Lab. Invest., 54: 442, 1986.
14. DeKlerk, D. P., Coffey, D. S., Ewing, L. L., McDermott, I. R., Reiner, W. G., Robinson, C. H., Scott, W. W., Strandberg, J. D., Talalay, P., Walsh, P. C., Wheaton, L. G. and Zirkin, B. R.: Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J. Clin. Invest., 64: 842, 1979.
15. Barrack, E. R. and Berry, S. J.: DNA synthesis in the canine prostate: effects of androgen and estrogen treatment. Prostate, 10: 45, 1987.
16. O'Shea, J. D.: Studies on the canine prostate gland. I. Factors influencing its size and weight. J. Comp. Pathol., 72: 321, 1962.
17. Shah, I. A., Schlageter, M.-O., Stinnett, P. and Lechago, J.: Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Modern Pathol., 4: 220, 1991.
18. Chevalier, S., Landry, D. and Chapdelaine, A.: Phosphotyrosine phosphatase activity of human and canine acid phosphatases of prostatic origin. Prostate, 12: 209, 1988.
19. Isaacs, W. B. and Shaper, J. H.: Immunological localization and quantitation of the androgen-dependent secretory protease of the canine prostate. Endocrinology, 117: 1512, 1985.
20. Ross, A. H., Baltimore, D. and Eisen, H. N.: Phosphotyrosine-containing proteins isolated by affinity chromatography with antibodies to a synthetic hapten. Nature, 294: 654, 1981.
21. Wang, J. Y. J.: Antibodies for phosphotyrosine: analytical and preparative tool for tyrosylphosphorylated proteins. Anal. Biochem., 172: 1, 1988.
22. Leav, I., Merk, F. B., Ofner, P., Goodrich, G., Kwan, P. W. L., Stein, B. M., Sar, M. and Stumpf, E.: Bipotentiality of response to sex hormones by the prostate of castrated or hypophysectomized dogs. Am. J. Pathol., 93: 69, 1978.
23. Visakorpi, T., Kallioniemi, O.-P., Koivula, T., Harvey, J. and Isola, J.: Expression of epidermal growth factor receptor and erbB2 (her-2/neu) oncoprotein in prostatic carcinoma. Modern Pathol., 5: 643, 1992.
24. Fiorelli, G., De Bellis, A., Longo, A., Giannini, S., Natali, A., Costantini, A., Vannelli, G. B. and Serio, M.: Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J. Clin. Endocrinol. Metabol., 72: 740, 1991.
25. Wells, A., Bishop, J. M. and Helmeste, D.: Amplified gene for the epidermal growth factor receptor in a human glioblastoma cell line encodes an enzymatically inactive protein. Mol. Cell. Biol., 8: 4561, 1988.
26. Tessier, S., Chapdelaine, A. and Chevalier, S.: Alkali-resistant protein phosphorylation and tyrosine kinase activity of epithelial cell types from normal and metaplastic canine prostates. Mol. Cell. Endocrinol., 66: 59, 1989.
27. Tessier, S., Chapdelaine, A. and Chevalier, S.: Effect of vanadate on protein phosphorylation and on acid phosphatase activity in the canine prostate. Mol. Cell. Endocrinol., 64: 87, 1989.
28. Lin, M. F., DaVolio, J. and Arenas-Garcia, R.: Expression of human prostatic acid phosphatase activity and growth of prostate carcinoma cells. Cancer Res., 52: 4600, 1992.
29. Lin, M. F. and Clinton, G.: The epidermal growth factor receptor from prostate cells is dephosphorylated by prostate specific phosphotyrosyl phosphatase. Mol. Cell. Biol., 8: 5477, 1988.
30. Tonks, N. K., Diltz, C. D. and Fisher, E. H.: Purification of the major protein tyrosine phosphatase of human placenta. J. Biol. Chem., 263: 6277, 1988.
31. Boissonneault, M., Chapdelaine, A. and Chevalier, S.: The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases. Mol. Cell. Biochem., in press, 1995.